Alzheimer’s Disease Neuroimaging Initiative

4453 Total Publications

Year	Title	Author	Journal
2016	Label-aligned multi-task feature learning for multimodal classification of Alzheimer's disease and mild cognitive impairment	Zu C1, Jie B1,2, Liu M1, Chen S1, Shen D3,4, Zhang D5; Alzheimer’s Disease Neuroimaging Initiative	Journal Brain Imaging Behavior;
2016	Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults	S. L. Risacher, B. C. McDonald, E. F. Tallman, J. D. West, M. R. Farlow, F. W. Unverzagt, S. Gao, M. Boustani, P. K. Crane, R. C. Petersen, C. R. Jack, Jr., W. J. Jagust, P. S. Aisen, M. W. Weiner, A. J. Saykin and I. Alzheimer's Disease Neuroimaging	Journal JAMA Neurol;
2016	Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease	J. S. Yokoyama, Y. Wang, A. J. Schork, W. K. Thompson, C. M. Karch, C. Cruchaga, L. K. McEvoy, A. Witoelar, C. H. Chen, D. Holland, J. B. Brewer, A. Franke, W. P. Dillon, D. M. Wilson, P. Mukherjee, C. P. Hess, Z. Miller, L. W. Bonham, J. Shen, G. D. Rabinovici, H. J. Rosen, B. L. Miller, B. T. Hyman, G. D. Schellenberg, T. H. Karlsen, O. A. Andreassen, A. M. Dale and R. S. Desikan	Journal JAMA Neurol;
2016	Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta-analysis	Crane PK1, Gibbons LE1, Dams-O'Connor K2, Trittschuh E3, Leverenz JB4, Keene CD5, Sonnen J6, Montine TJ7, Bennett DA8, Leurgans S8, Schneider JA9, Larson EB10	Journal JAMA Neurol;
2016	Asymptomatic Alzheimer disease: Defining resilience.	T. J. Hohman, D. G. McLaren, E. C. Mormino, K. A. Gifford, D. J. Libon, A. L. Jefferson and I. Alzheimer's Disease Neuroimaging	Journal Neurology;
2016	Clusters of male and female Alzheimer’s disease patients in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database	D. Gamberger, B. Zenko, A. Mitelpunkt, N. Shachar and N. Lavrac	Journal Brain Inform;
2016	Genetic Association of HLA Gene Variants with MRI Brain Structure in Alzheimer’s Disease	Z. X. Wang, Y. Wan, L. Tan, J. Liu, H. F. Wang, F. R. Sun, M. S. Tan, C. C. Tan, T. Jiang, L. Tan, J. T. Yu and I. Alzheimer's Disease Neuroimaging	Journal Mol Neurobiol;
2016	Detection of Alzheimer’s disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers	C. A. DeMarshall, E. P. Nagele, A. Sarkar, N. K. Acharya, G. Godsey, E. L. Goldwaser, M. Kosciuk, U. Thayasivam, M. Han and B. Belinka	Journal Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;
2016	CSF Aβ1–42 – an excellent but complicated Alzheimer's biomarker – a route to standardisation	J. A. Kuhlmann, A. U., J. Pannee, M. Bjerke, E. Portelius, A. Leinenbach, T. Bittner, M. Korecka, R. G. Jenkins and Vanderstichele	Journal Clinica Chimica Acta;
2016	Impact of PICALM and CLU on hippocampal degeneration	X. Yang, J. Li, B. Liu, Y. Li and T. Jiang	Journal Hum Brain Mapp;